Sophia Antipolis, 16 August 2012: A new definition of heart attack will be presented at the ESC Congress 2012. The third universal definition of myocardial infarction (MI) clarifies the controversial area of procedural related MI and will be the gold standard for diagnosis and clinical trial endpoints.
It’s just one of the sessions not to miss at this year’s ESC Congress, being held 25-29 August in Munich, Germany.
The Congress kicks off on Saturday 25 August, with a fuller scientific programme than ever. For the first time there is a full press programme on Saturday with three press conferences.
The press conference schedule is packed with the latest science and great news stories. Long awaited results of clinical trials such as ALTITUDE, FAME II, FAST MI, PROTECT, De FACTO, WOEST and TRILOGY ACS will be announced. Other groundbreaking content has been grouped under eight themed headings. New techniques such as Renal Denervation will be among the spotlights of our press conferences: come and hear about how zapping overactive kidney nerves can lower blood pressure in patients who don’t respond to drugs. And how politicians can influence lifestyle changes to prevent cardiovascular disease.
Professor Michael Böhm, Chairperson of the ESC Congress Programme Committee, said: “The ESC Congress is the top international cardiovascular event of the year and 2012 has more new science than ever. Hold the front page for results presented in Hot Line sessions. These are some of the most exciting sessions in the cardiovascular calendar and will influence future treatment of heart disease.”
Online registration is now closed, but dedicated desks for Press Registration will be available on-site from the morning of Friday 24 August. For more information contact the ESC press office at firstname.lastname@example.org
About the European Society of Cardiology (ESC)
The European Society of Cardiology (ESC) represents more than 75,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved